Julia Bandow is a full professor of Applied Microbiology at Ruhr University Bochum/Germany. She received a PhD in Microbiology from Ernst-Moritz-Arndt University of Greifswald/Germany in 2002 and then joined Pfizer Global Research and Development, Ann Arbor Michigan/USA, where she utilized proteomic methods to identify drug mechanisms of actions and biomarkers of disease and drug efficacy. In 2008 after six years in industry, she joined RUB to pursue an academic career.
Bandow’s research interests focus on antibacterial strategies. In 2014 she was honored with the Research Award of the German Microbiology Society (VAAM) for her contributions to antibiotic research. Her current projects include the search for novel antibiotics on the basis of natural products and metalloantibiotics as well as applications of non-equilibrium plasma in microbiology and biotechnology. In particular, Bandow is interested in the effects of plasma treatment on bacteria and proteins, and in the bacterial defense mechanisms
Daniela Boehm is a Science Foundation Ireland Starting Investigator and assistant lecturer in the School of Food Science and Environmental Health at Technological University Dublin. Her research focuses on investigating the application of plasma and plasma activated liquids in microbial decontamination, with an emphasis on understanding the translation of liquid chemistry to biological effect. The safety of plasma activated liquids is one of Daniela’s topics of interest including studies on cytotoxic and genotoxic effects, the action of reactive oxygen and nitrogen species and development of resistances.
Cristina Canal is Associate professor at the Department of Materials Science and Engineering, at the Technical University of Catalonia (UPC), within the Biomaterials, Biomechanics and Tissue Engineering Group. She serves as deputy director of the Center for Research in Biomedical Engineering (CREB). Her research has been recognized with different awards, including the “2018 Early Career Award in Plasma Medicine“ and the "2020 ICREA Academia".
Her interests are focused in cold plasmas for biomedical applications, particularly investigating cold atmospheric pressure plasmas and their interactions with liquids and biomaterials for therapeutic applications. Together with an interdisciplinary team she aims at understanding the interactions and mechanisms beyond the interactions of reactive species from the gas phase with biomaterials in the liquid phase, and their biological outcomes, especially with regard to cancer therapies.
Alexander Fridman, Ph.D., D.Sc., is Nyheim Chair Professor, Director of the Nyheim Plasma Institute of Drexel University, and fellow of US National Academy of Inventors. He is a world leader in plasma science and technology, he made significant contribution to plasma fundamentals and applications to material processing, electronics, fuel conversion, environmental control, cosmetics, agriculture, and food processing. Prof. Fridman is a world pioneer of Plasma Medicine, and Founding President of the International Society of Plasma Medicine. Prof. Fridman is a recipient of numerous prestigious awards, including International Plasma Medicine Award, State Price of the USSR, Stanley Kaplan Distinguished Professorship in Chemical Kinetics and Energy Systems, George Soros Distinguished Professorship in Physics, Chernobyl Nuclear Accident Medal, Kurchatov Medal for Scientific Achievements in Nuclear and Plasma Sciences, Reactive Plasma Award, as well as Plasma Chemistry Award, one the world highest in plasma field. He holds more than 30 patents, wrote 8 monograph books and more than thousand journal papers.
Matteo Gherardi is associate professor at the University of Bologna. His scientific activity is focused on the development of innovative plasma technologies and their applications in industrially and socially relevant fields. MG expertise is rooted in plasma engineering and physics (design and optimization of plasma systems and processes, plasma diagnostics) and his main research interests are i) equilibrium and non-equilibrium plasmas at atmospheric or sub-atmospheric pressures, ii) material processing, iii) plasma application in the agrifood and medical fields, iv) plasma characterization and v) development of monitoring and control strategies for plasma processes.
MG most recent research activities deal with i) thin film deposition for developing antimicrobial surfaces, ii) development of energy-based and chemistry-based control strategies for plasma processes, iii) investigation of plasma-aerosol systems, iv) design of plasma-based technologies for COVID containment and v) up-scaling of plasma systems.
Dr. Petr Lukeš is a senior researcher and the Head of the Department of Pulse Plasma Systems at the Institute of Plasma Physics of the Czech Academy of Sciences, Prague, Czech Republic. He is specialized in the research of elementary chemical and physical processes induced by non-thermal plasma of electrical discharges in liquids and in gas-liquid environments; environmental and biomedical applications of underwater plasma; diagnostics of chemical products of electrical discharges in liquids and gas/liquid interfaces; investigation of effects of discharge plasma on organic compounds and microorganisms in liquids.
Nevena Puač finished her postgraduate studies and obtained PhD at the Faculty of Physics, University of Belgrade in 2007. She is a research professor in the Centre of excellence for non-equilibrium processes at the Institute of Physics Belgrade. Her scientific interests include low temperature plasma physics, construction and diagnostic of CCP/ICP RF and MW plasmas, atmospheric pressure plasmas, power measurements with derivative probes and applications of plasmas in biology, medicine, stomatology and agriculture.
Carola van Pul is a clinical physicist in Maxima Medical Center and also an Associate Professor and Chair of Clinical Physics at Eindhoven University of Technology (TU/e). Her fields of expertise concerns general clinical physics - for radiology, nuclear medicine, radiation protection, with a particular specialization in medical technology used for intensive and mother-and-child care. Next to her clinical tasks as clinical physicist in MMC, Carola is an active researcher. Focus of her research is currently on patient monitoring for (neonatal) intensive care, using machine learning for early detection of deterioration and development of alarms for the complex medical alarm systems using ICT networks.
Rob Short has a track record of research and commercialisation in the fields of plasma, biomaterial science and cell therapy. He studied Chemistry (BSc) and Physical Chemistry (PhD) at the University of Durham, joining the University of Sheffield in 1988, where he held the Chair of Material and Biomaterial Chemistry from 2001. During this period, he was a founder Director of two spin-out companies, CellTran Ltd and Plasso Technology. In 2006 he joined UniSA, Australia where he held the positions of Director: Mawson (Research) Institute, Dean: Research of Science and Engineering and Pro Vice Chancellor (IT and Engineering) until 2016, since when he has been Professor and Director of the Material Science Institute at Lancaster University, UK.
Thomas von Woedtke studied Pharmacy at Greifswald University, Germany. He received the Doctoral Degree in 1995 in Pharmaceutical Technology, followed by the Habilitation degree in 2007. Since 2008 he is Research Program Manager Plasma Medicine at the Leibniz Institute for Plasma Science and Technology (INP) Greifswald, Germany, and since 2020 Member of the Board of INP. He holds a professorship for Plasma Medicine at Greifswald University Medicine since 2011.
International Conference on Plasma MedicineRegistration website for International Conference on Plasma Medicine
International Conference on Plasma Medicinereservations@tue.nl
International Conference on Plasma Medicinereservations@tue.nlhttps://www.icpm9.eu
International Conference on Plasma MedicineInternational Conference on Plasma Medicine0.00EUROnlineOnly2019-01-01T00:00:00ZTo be announcedTo be announced